DI-011 Analysis of off-label use in biological therapies

BackgroundBiologics are usually prescribed off-label in severe immune mediated inflammatory diseases. Unfortunately, off-label prescription is sometimes hampered in these diseases due to a lack of evidence of effectiveness.PurposeTo assess the risk and outcome of biological therapies on off-label pr...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	European journal of hospital pharmacy. Science and practice 2017-03, Vol.24 (Suppl 1), p.A117-A118
Hauptverfasser:	Lorenzo, M Gutiérrez, Araujo, D Furones, Alarcón, A Linares, Castillo, I Muñoz
Format:	Artikel
Sprache:	eng
Schlagworte:	Biological products Immunotherapy Patients Pharmacy Sarcoidosis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!